Wealth Preservation Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-614
Closed -$17.2K 706
2026
Q1
$17.2K Buy
614
+302
+97% +$8.04K 0.01% 334
2025
Q4
$7.77K Buy
312
+33
+12% +$832 ﹤0.01% 320
2025
Q3
$7.11K Sell
279
-326
-54% -$8.05K ﹤0.01% 323
2025
Q2
$14.7K Sell
605
-60
-9% -$1.4K 0.01% 273
2025
Q1
$16.9K Buy
+665
New +$17.4K 0.01% 277

Other funds holding PFE

Wealth Preservation Advisors's PFE Position: Q2 2026 in Review

Wealth Preservation Advisors sold out of Pfizer (PFE) in Q2 2026, closing a stake of 614 shares — an estimated $17.2K sold.

Wealth Preservation Advisors first reported a position in PFE in Q1 2025 and held it in 5 quarters. The position peaked at $17.2K in Q1 2026. 2,835 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Wealth Preservation Advisors reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Wealth Preservation Advisors sold 614 Pfizer shares in Q2 2026, an estimated $17.2K.
  • Wealth Preservation Advisors first reported a position in Pfizer in Q1 2025 and held it in 5 quarters.
  • Wealth Preservation Advisors's Pfizer position peaked at $17.2K in Q1 2026.
  • 2,835 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Wealth Preservation Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.